Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zihong Chen

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|September 1, 2007
Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirusSanthana G Devaraj, Nan Wang, Zhongbin Chen, et al.
Translational Oncology|July 30, 2024
Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective studyJiaqi He, Guoqing Luo, Shen Liu, et al.
Scientific Reports|August 13, 2024
Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort studyHaiqing Luo, Guihua Yi, Haifeng Tang, et al.
Non-Coding RNA Research|February 3, 2025
Identification and validation of lncRNA mutation hotspot SNPs associated with myasthenia gravis susceptibilityNi He, Liting Tian, Jingnan Jin, et al.
Journal of Neuroinflammation|August 7, 2024
FOSL1-mediated LINC01566 negatively regulates CD4<sup>+</sup> T-cell activation in myasthenia gravisLifang Li, Danyang Li, Jingnan Jin, et al.
Cancer Medicine|April 10, 2024
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysisYaxiong Zhang, Zihong Chen, Yu Liu, et al.
Life Sciences|March 7, 2015
Inhibition of microglial activation by elderberry extracts and its phenolic componentsAgnes Simonyi, Zihong Chen, Jinghua Jiang, et al.
Neurochemistry International|May 12, 2016
Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytesDeepa Ajit, Agnes Simonyi, Runting Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2024
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methodsMengting Shi, Lanlan Pang, Huaqiang Zhou, et al.
Molecular Plant|May 30, 2025
SeedLLM·Rice: A large language model integrated with rice biological knowledge graphFan Yang, Huanjun Kong, Jie Ying, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|September 1, 2007
Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirusSanthana G Devaraj, Nan Wang, Zhongbin Chen, et al.
Translational Oncology|July 30, 2024
Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective studyJiaqi He, Guoqing Luo, Shen Liu, et al.
Scientific Reports|August 13, 2024
Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort studyHaiqing Luo, Guihua Yi, Haifeng Tang, et al.
Non-Coding RNA Research|February 3, 2025
Identification and validation of lncRNA mutation hotspot SNPs associated with myasthenia gravis susceptibilityNi He, Liting Tian, Jingnan Jin, et al.
Journal of Neuroinflammation|August 7, 2024
FOSL1-mediated LINC01566 negatively regulates CD4<sup>+</sup> T-cell activation in myasthenia gravisLifang Li, Danyang Li, Jingnan Jin, et al.
Cancer Medicine|April 10, 2024
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysisYaxiong Zhang, Zihong Chen, Yu Liu, et al.
Life Sciences|March 7, 2015
Inhibition of microglial activation by elderberry extracts and its phenolic componentsAgnes Simonyi, Zihong Chen, Jinghua Jiang, et al.
Neurochemistry International|May 12, 2016
Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytesDeepa Ajit, Agnes Simonyi, Runting Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2024
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methodsMengting Shi, Lanlan Pang, Huaqiang Zhou, et al.
Molecular Plant|May 30, 2025
SeedLLM·Rice: A large language model integrated with rice biological knowledge graphFan Yang, Huanjun Kong, Jie Ying, et al.
Pageof 6